Development
Vitro, S.A.B. de C.V.
VITOF
$0.15
-$0.51-77.27%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 0.44% | 7.08% | 9.00% | 16.50% | 26.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.44% | 7.08% | 9.00% | 16.50% | 26.80% |
| Cost of Revenue | 1.28% | 2.23% | 4.44% | 8.56% | 22.08% |
| Gross Profit | -2.19% | 24.07% | 24.97% | 47.20% | 44.13% |
| SG&A Expenses | -0.81% | 9.38% | 12.54% | 12.53% | 23.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3,472.57% | 69.19% | 57.07% | 146.88% | -98.71% |
| Total Operating Expenses | 1.55% | 4.31% | 6.23% | 15.59% | 20.20% |
| Operating Income | -16.72% | 63.36% | 86.30% | 34.89% | 751.16% |
| Income Before Tax | -28.63% | 162.52% | 62.84% | 99.90% | 1,030.91% |
| Income Tax Expenses | -122.23% | -117.13% | -419.54% | -119.96% | 574.77% |
| Earnings from Continuing Operations | 189.96% | 323.59% | 92.01% | 106.42% | -200.17% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -56.86% | 41.41% | -54.95% | 193.85% | -19.05% |
| Net Income | 190.82% | 320.32% | 91.15% | 106.58% | -205.51% |
| EBIT | -16.72% | 63.36% | 86.30% | 34.89% | 751.16% |
| EBITDA | -4.70% | 28.17% | 31.73% | 15.72% | 77.08% |
| EPS Basic | 200.00% | 300.00% | 100.00% | 125.45% | -160.87% |
| Normalized Basic EPS | -21.74% | 148.73% | 68.91% | 937.04% | 1,085.71% |
| EPS Diluted | 200.00% | 300.00% | 100.00% | 125.45% | -160.87% |
| Normalized Diluted EPS | -21.74% | 148.73% | 68.91% | 937.04% | 1,085.71% |
| Average Basic Shares Outstanding | -9.18% | 5.08% | -4.42% | -74.11% | 17.60% |
| Average Diluted Shares Outstanding | -9.18% | 5.08% | -4.42% | -74.11% | 17.60% |
| Dividend Per Share | -- | -- | -- | 200.94% | -- |
| Payout Ratio | -- | -- | -- | 1,520.34% | -- |